Skip to main content


This ability is being harnessed by start-ups and companies in the microbiome-based therapeutics market to create aimed at treating conditions, which have been shown to have a link with imbalance in the microbiome. The human microbiome market has been analyzed by studying it as two individual markets, the microbiome-based diagnostics market and the microbiome-based therapeutics market.